Thyrocare Technologies Limited — Board/Management Information 2021

Jan 22, 2021

==> picture [42 x 356] intentionally omitted <==

==> picture [10 x 155] intentionally omitted <==

ocare� Thyr Think Thyroid. Think Thyrocare.

January 22, 2021

To, National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeeboy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai- 400 001 Dear Sir/Madam,

Sub: Prior Intimation under Regulation 29 (I) (a) of SEBJ (Listing Obligations and Disclosure Requirements) Regulations, 2015.

--o--

Pursuant to Regulation 29 (1) (a) of SEBJ (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday, January 30, 2021, to inter alia, consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter / nine months ended December 31, 2020, to consider and decide on payment of 2[nd ] Interim Dividend, if any, for the financial year 2020-21 and to decide on the appointment of new Auditors in the place of present Auditors (whose consecutive term of ten years would come to an end as at the conclusion of ensuing Annual General Meeting), subject to approval of the Members at the general meeting.

Intimation of the above meeting of the Board of Directors is also being published in newspapers, as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [84 x 85] intentionally omitted <==

==> picture [81 x 39] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

Thyrocare Technologies Limited

9 D-37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 � enquiry@thyrocare.com (@ www.thyrocare.com

(CIN: L85110MH2000PLC123882)